Beckley Psytech Limited
Clinical trials sponsored by Beckley Psytech Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Nasal spray shows promise for depression that Won't quit Results expected Nov 2026 (estimated)
-
Psychedelic nasal spray shows promise for alcohol addiction in small trial
Disease control CompletedThis early-phase study tested a single nasal spray dose of BPL-003, a psychedelic drug, combined with psychological support in 13 adults with moderate to severe alcohol use disorder. The main goals were to check safety and tolerability, and to explore effects on drinking behavior…
Phase 2 • Sponsor: Beckley Psytech Limited • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Nasal spray aims to lift depression that antidepressants miss
Symptom relief CompletedResearchers are testing an experimental nasal spray called BPL-003 in adults with treatment-resistant depression, a form of severe depression that has not improved with standard antidepressants. The Phase 2 trial compares a higher dose with a very low dose, given as a single trea…
Phase 2 • Sponsor: Beckley Psytech Limited • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC